Credit Suisse’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-20,421
| Closed | -$217K | – | 3910 |
|
|
2016
Q2 | $217K | Buy |
20,421
+19,411
| +1,922% | +$206K | ﹤0.01% | 3530 |
|
|
2016
Q1 | $19K | Sell |
1,010
-3,126
| -76% | -$58.8K | ﹤0.01% | 3627 |
|
|
2015
Q4 | $110K | Buy |
4,136
+1,671
| +68% | +$44.4K | ﹤0.01% | 3832 |
|
|
2015
Q3 | $112K | Buy |
2,465
+108
| +5% | +$4.91K | ﹤0.01% | 3865 |
|
|
2015
Q2 | $75K | Buy |
2,357
+1,429
| +154% | +$45.5K | ﹤0.01% | 4127 |
|
|
2015
Q1 | $29K | Sell |
928
-1,787
| -66% | -$55.8K | ﹤0.01% | 4024 |
|
|
2014
Q4 | $103K | Buy |
2,715
+2,032
| +298% | +$77.1K | ﹤0.01% | 4047 |
|
|
2014
Q3 | $17K | Sell |
683
-2,796
| -80% | -$69.6K | ﹤0.01% | 3998 |
|
|
2014
Q2 | $103K | Sell |
3,479
-2,199
| -39% | -$65.1K | ﹤0.01% | 4102 |
|
|
2014
Q1 | $211K | Sell |
5,678
-1,298
| -19% | -$48.2K | ﹤0.01% | 3948 |
|
|
2013
Q4 | $289K | Buy |
6,976
+4,169
| +149% | +$173K | ﹤0.01% | 3660 |
|
|
2013
Q3 | $149K | Sell |
2,807
-1,503
| -35% | -$79.8K | ﹤0.01% | 3614 |
|
|
2013
Q2 | $230K | Buy |
+4,310
| New | +$230K | ﹤0.01% | 3401 |
|